Cargando…

Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression

Detalles Bibliográficos
Autores principales: Ikeda, Hiroaki, Ueno, Hiroaki, Kawamura, Ayumi, Imai, Naoko, Okamoto, Sachiko, Mineno, Junichi, Takesako, Kazutoh, Shiku, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288585/
http://dx.doi.org/10.1186/2051-1426-2-S3-P20
_version_ 1782351993535201280
author Ikeda, Hiroaki
Ueno, Hiroaki
Kawamura, Ayumi
Imai, Naoko
Okamoto, Sachiko
Mineno, Junichi
Takesako, Kazutoh
Shiku, Hiroshi
author_facet Ikeda, Hiroaki
Ueno, Hiroaki
Kawamura, Ayumi
Imai, Naoko
Okamoto, Sachiko
Mineno, Junichi
Takesako, Kazutoh
Shiku, Hiroshi
author_sort Ikeda, Hiroaki
collection PubMed
description
format Online
Article
Text
id pubmed-4288585
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42885852015-01-15 Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression Ikeda, Hiroaki Ueno, Hiroaki Kawamura, Ayumi Imai, Naoko Okamoto, Sachiko Mineno, Junichi Takesako, Kazutoh Shiku, Hiroshi J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288585/ http://dx.doi.org/10.1186/2051-1426-2-S3-P20 Text en Copyright © 2014 Ikeda et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Ikeda, Hiroaki
Ueno, Hiroaki
Kawamura, Ayumi
Imai, Naoko
Okamoto, Sachiko
Mineno, Junichi
Takesako, Kazutoh
Shiku, Hiroshi
Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
title Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
title_full Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
title_fullStr Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
title_full_unstemmed Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
title_short Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
title_sort tumor-specific donor lymphocyte infusion therapy with allogeneic t cells utilizing novel retrovirus vector silencing endogenous tcr expression
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288585/
http://dx.doi.org/10.1186/2051-1426-2-S3-P20
work_keys_str_mv AT ikedahiroaki tumorspecificdonorlymphocyteinfusiontherapywithallogeneictcellsutilizingnovelretrovirusvectorsilencingendogenoustcrexpression
AT uenohiroaki tumorspecificdonorlymphocyteinfusiontherapywithallogeneictcellsutilizingnovelretrovirusvectorsilencingendogenoustcrexpression
AT kawamuraayumi tumorspecificdonorlymphocyteinfusiontherapywithallogeneictcellsutilizingnovelretrovirusvectorsilencingendogenoustcrexpression
AT imainaoko tumorspecificdonorlymphocyteinfusiontherapywithallogeneictcellsutilizingnovelretrovirusvectorsilencingendogenoustcrexpression
AT okamotosachiko tumorspecificdonorlymphocyteinfusiontherapywithallogeneictcellsutilizingnovelretrovirusvectorsilencingendogenoustcrexpression
AT minenojunichi tumorspecificdonorlymphocyteinfusiontherapywithallogeneictcellsutilizingnovelretrovirusvectorsilencingendogenoustcrexpression
AT takesakokazutoh tumorspecificdonorlymphocyteinfusiontherapywithallogeneictcellsutilizingnovelretrovirusvectorsilencingendogenoustcrexpression
AT shikuhiroshi tumorspecificdonorlymphocyteinfusiontherapywithallogeneictcellsutilizingnovelretrovirusvectorsilencingendogenoustcrexpression